Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05743283

Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds

Efficacy of SynEx™ Wound Rinse in Civilian Surrogates of Combat Injury Wounds

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Synedgen, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this interventional study is to compare SynEx Wound Cleanser with the current routine care (Saline) in traumatic wounds. Participants with gunshot, penetrating or burn wounds who participate will be asked to attend up to four study visits, use the assigned wound cleanser and complete brief surveys about their healing and well-being related to the wound healing.

Conditions

Interventions

TypeNameDescription
DEVICESynEx Wound CleanserSynEx is a concentrated form of SynePure®, an FDA 510(k) cleared aqueous, osmotically balanced wound cleanser containing patented chitosan derivatives. The ingredients are USP purified water, chitosan arginine (a patented chitosan derivative), sorbitol powder, and betaine. SynEx cleanser is packaged in a collapsible plastic pouch for reconstitution in water before debriding and cleansing a wound.
OTHERSalineThe saline solution is composed of water and salt. It is packaged in a collapsible plastic pouch.

Timeline

Start date
2023-04-12
Primary completion
2025-09-01
Completion
2025-09-01
First posted
2023-02-24
Last updated
2024-05-16

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05743283. Inclusion in this directory is not an endorsement.